| NCT03399955 |
Short Course Regimens for Treatment of PKDL (Sudan) |
https://ClinicalTrials.gov/show/NCT03399955 |
Recruiting |
Drugs for Neglected Diseases |
2021-05-09 |
| NCT01484548 |
Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT01484548 |
Completed |
IDRI |
2012-08-31 |
| NCT03311607 |
Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh |
https://ClinicalTrials.gov/show/NCT03311607 |
Completed |
Medecins Sans Frontieres, Netherlands |
2015-10-14 |
| NCT03303898 |
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - |
https://ClinicalTrials.gov/show/NCT03303898 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2017-11-10 |
| NCT03269006 |
Improved Case Detection and Vector Control for Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT03269006 |
Completed |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2016-04-30 |
| NCT03096457 |
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia |
https://ClinicalTrials.gov/show/NCT03096457 |
Completed |
Fundacion Nacional de Dermatologia |
2018-03-18 |
| NCT03023111 |
Miltefosine and GM-CSF in Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT03023111 |
Completed |
Hospital Universitário Professor Edgard Santos |
2019-08-09 |
| NCT02919605 |
Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis |
https://ClinicalTrials.gov/show/NCT02919605 |
Completed |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2016-01-31 |
| NCT02894008 |
A Study of a New Leishmania Vaccine Candidate ChAd63-KH |
https://ClinicalTrials.gov/show/NCT02894008 |
Completed |
University of York |
2019-09-30 |
| NCT02687971 |
Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨ |
https://ClinicalTrials.gov/show/NCT02687971 |
Completed |
Drugs for Neglected Diseases |
2019-08-10 |
| NCT02656797 |
Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT02656797 |
Recruiting |
Soroka University Medical Center |
2020-01-31 |
| NCT02431143 |
Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa |
https://ClinicalTrials.gov/show/NCT02431143 |
Completed |
Drugs for Neglected Diseases |
2016-04-30 |
| NCT02193022 |
Miltefosine for Children With PKDL |
https://ClinicalTrials.gov/show/NCT02193022 |
Completed |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2019-06-30 |
| NCT02071758 |
Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT02071758 |
Completed |
IDRI |
2015-12-31 |
| NCT01301937 |
Low Antimonial Dosage in American Mucosal Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01301937 |
Recruiting |
Oswaldo Cruz Foundation |
2020-12-31 |
| NCT01301924 |
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01301924 |
Completed |
Oswaldo Cruz Foundation |
2016-04-30 |
| NCT01300975 |
Intralesional Antimony for Bolivian Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01300975 |
Completed |
Fundacion Nacional de Dermatologia |
2012-07-31 |
| NCT02011958 |
Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. |
https://ClinicalTrials.gov/show/NCT02011958 |
Completed |
Drugs for Neglected Diseases |
2016-08-31 |
| NCT01988909 |
WR 279,396 for the Treatment of Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01988909 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-12-31 |
| NCT01975051 |
A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) |
https://ClinicalTrials.gov/show/NCT01975051 |
Completed |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2014-09-30 |
| NCT01845727 |
Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia |
https://ClinicalTrials.gov/show/NCT01845727 |
Completed |
Drugs for Neglected Diseases |
2016-05-31 |
| NCT02025491 |
Liposomal Amphotericin in Disseminated Leishmaniasis |
https://ClinicalTrials.gov/show/NCT02025491 |
Completed |
Hospital Universitário Professor Edgard Santos |
2013-02-28 |
| NCT01790659 |
Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama |
https://ClinicalTrials.gov/show/NCT01790659 |
Completed |
U.S. Army Medical Research and Development Command |
2016-01-31 |
| NCT01766830 |
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) |
https://ClinicalTrials.gov/show/NCT01766830 |
Completed |
University Hospital, Geneva |
2014-10-31 |
| NCT01751048 |
LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine |
https://ClinicalTrials.gov/show/NCT01751048 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-01-31 |
| NCT01661296 |
Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India |
https://ClinicalTrials.gov/show/NCT01661296 |
Completed |
Sarder Patel Medical College |
2011-08-31 |
| NCT01644682 |
Replacement of Insecticides to Control Visceral Leishmaniasis (VL) |
https://ClinicalTrials.gov/show/NCT01644682 |
Completed |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2014-12-31 |
| NCT01536795 |
A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01536795 |
Completed |
U.S. Army Medical Research and Development Command |
2007-02-28 |
| NCT01464242 |
Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01464242 |
Completed |
Centro Internacional de Entrenamiento e Investigaciones Médicas |
2015-01-31 |
| NCT01462500 |
Pharmacokinetics of Miltefosine in Children and Adults |
https://ClinicalTrials.gov/show/NCT01462500 |
Completed |
Centro Internacional de Entrenamiento e Investigaciones Médicas |
2014-05-31 |
| NCT01381055 |
Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01381055 |
Completed |
Hospital Universitário Professor Edgard Santos |
2015-01-31 |
| NCT01380314 |
Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01380314 |
Completed |
Foundation Fader |
2010-03-31 |
| NCT01377974 |
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01377974 |
Completed |
Brasilia University Hospital |
2013-06-30 |
| NCT01360762 |
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study |
https://ClinicalTrials.gov/show/NCT01360762 |
Completed |
Institute of Tropical Medicine, Belgium |
2015-11-30 |
| NCT01328457 |
An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh |
https://ClinicalTrials.gov/show/NCT01328457 |
Completed |
PATH |
2011-05-31 |
| NCT04340128 |
Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL) |
https://ClinicalTrials.gov/show/NCT04340128 |
Completed |
Tehran University of Medical Sciences |
2007-10-31 |
| NCT03999970 |
A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol |
https://ClinicalTrials.gov/show/NCT03999970 |
Completed |
University of York |
2019-12-23 |
| NCT03969134 |
A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL |
https://ClinicalTrials.gov/show/NCT03969134 |
Recruiting |
University of York |
2021-10-31 |
| NCT03929016 |
Single Oral Dose Escalation Study of DNDI-0690 in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT03929016 |
Recruiting |
Drugs for Neglected Diseases |
2019-09-30 |
| NCT03829917 |
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT03829917 |
Recruiting |
Fundacion Nacional de Dermatologia |
2020-02-01 |
| NCT03641339 |
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans |
https://ClinicalTrials.gov/show/NCT03641339 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-08-13 |
| NCT03636659 |
Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition |
https://ClinicalTrials.gov/show/NCT03636659 |
Completed |
Aurobindo Pharma Ltd |
2019-04-05 |
| NCT03445897 |
Miltefosine Plus IL Pentamidine for Bolivian CL |
https://ClinicalTrials.gov/show/NCT03445897 |
Completed |
AB Foundation |
2018-01-31 |
| NCT01240473 |
A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh |
https://ClinicalTrials.gov/show/NCT01240473 |
Completed |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2008-03-31 |
| NCT01122771 |
Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh |
https://ClinicalTrials.gov/show/NCT01122771 |
Completed |
Drugs for Neglected Diseases |
2014-03-31 |
| NCT01083576 |
Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama |
https://ClinicalTrials.gov/show/NCT01083576 |
Completed |
U.S. Army Medical Research and Development Command |
2011-06-30 |
| NCT01069198 |
A Community Trial for Visceral Leishmaniasis (VL) |
https://ClinicalTrials.gov/show/NCT01069198 |
Completed |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2010-10-31 |
| NCT01067443 |
Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa |
https://ClinicalTrials.gov/show/NCT01067443 |
Completed |
Drugs for Neglected Diseases |
2011-06-30 |
| NCT01050907 |
Miltefosine to Treat Mucocutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01050907 |
Completed |
Knight Therapeutics (USA) Inc |
2015-02-28 |
| NCT01050777 |
Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01050777 |
Completed |
Tehran University of Medical Sciences |
2012-01-31 |
| NCT01032382 |
Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) |
https://ClinicalTrials.gov/show/NCT01032382 |
Completed |
U.S. Army Medical Research and Development Command |
2011-03-31 |
| NCT01032187 |
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children |
https://ClinicalTrials.gov/show/NCT01032187 |
Completed |
University of Brasilia |
2010-01-31 |
| NCT01011309 |
A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT01011309 |
Completed |
IDRI |
2011-05-31 |
| NCT00996463 |
Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients |
https://ClinicalTrials.gov/show/NCT00996463 |
Completed |
Waisenmedizin e. V. Promoting Access to Essential Medicine |
2010-09-30 |
| NCT00982774 |
Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL |
https://ClinicalTrials.gov/show/NCT00982774 |
Completed |
IDRI |
2011-04-30 |
| NCT00973128 |
Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00973128 |
Completed |
Hospital Universitário Professor Edgard Santos |
2006-10-31 |
| NCT00947362 |
Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul |
https://ClinicalTrials.gov/show/NCT00947362 |
Completed |
Waisenmedizin e. V. Promoting Access to Essential Medicine |
NA |
| NCT00884377 |
Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00884377 |
Completed |
U.S. Army Medical Research and Development Command |
2009-01-31 |
| NCT00876824 |
To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar |
https://ClinicalTrials.gov/show/NCT00876824 |
Completed |
Bharat Serums and Vaccines Limited |
2011-01-31 |
| NCT02530697 |
The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil |
https://ClinicalTrials.gov/show/NCT02530697 |
Recruiting |
University of Brasilia |
2020-07-31 |
| NCT03294161 |
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT03294161 |
Completed |
Hospital Universitário Professor Edgard Santos |
2017-04-30 |
| NCT03129646 |
Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa |
https://ClinicalTrials.gov/show/NCT03129646 |
Recruiting |
Drugs for Neglected Diseases |
2019-11-30 |
| NCT00703924 |
Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World |
https://ClinicalTrials.gov/show/NCT00703924 |
Completed |
U.S. Army Medical Research and Development Command |
2004-11-30 |
| NCT00696969 |
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00696969 |
Completed |
Drugs for Neglected Diseases |
2010-01-31 |
| NCT00662012 |
Sodium Stibogluconate Treatment of Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00662012 |
Completed |
U.S. Army Medical Research and Development Command |
2007-10-31 |
| NCT00657618 |
Use of Sodium Stibogluconate as a Treatment for Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00657618 |
Completed |
U.S. Army Medical Research and Development Command |
2010-04-30 |
| NCT00633009 |
Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen |
https://ClinicalTrials.gov/show/NCT00633009 |
Completed |
Nielsen BioSciences, Inc. |
2009-09-30 |
| NCT00629031 |
An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00629031 |
Completed |
Banaras Hindu University |
2008-02-29 |
| NCT00628719 |
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00628719 |
Completed |
Banaras Hindu University |
2008-08-31 |
| NCT00606580 |
Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) |
https://ClinicalTrials.gov/show/NCT00606580 |
Completed |
U.S. Army Medical Research and Development Command |
2011-07-31 |
| NCT00604955 |
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00604955 |
Completed |
PATH |
2008-12-31 |
| NCT00600548 |
Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil) |
https://ClinicalTrials.gov/show/NCT00600548 |
Completed |
Hospital Universitário Professor Edgard Santos |
2009-03-31 |
| NCT00523965 |
Combination Therapy in Indian Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00523965 |
Completed |
Banaras Hindu University |
2009-08-31 |
| NCT00497601 |
A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar |
https://ClinicalTrials.gov/show/NCT00497601 |
Completed |
Banaras Hindu University |
2008-07-31 |
| NCT00490230 |
Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application |
https://ClinicalTrials.gov/show/NCT00490230 |
Completed |
U.S. Army Medical Research and Development Command |
2007-06-30 |
| NCT00486382 |
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India |
https://ClinicalTrials.gov/show/NCT00486382 |
Completed |
IDRI |
2008-11-30 |
| NCT00480883 |
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol |
https://ClinicalTrials.gov/show/NCT00480883 |
Completed |
Combined Military Hospital, Pakistan |
2008-06-30 |
| NCT00471705 |
Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia. |
https://ClinicalTrials.gov/show/NCT00471705 |
Completed |
Universidad de Antioquia |
2008-08-31 |
| NCT00469495 |
Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00469495 |
Completed |
Hospital Universitário Professor Edgard Santos |
2008-09-30 |
| NCT00381394 |
A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. |
https://ClinicalTrials.gov/show/NCT00381394 |
Completed |
GlaxoSmithKline |
2007-09-14 |
| NCT00373776 |
Miltefosine for Mucosal Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00373776 |
Completed |
AB Foundation |
NA |
| NCT00373568 |
Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00373568 |
Completed |
AB Foundation |
NA |
| NCT00371995 |
Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar |
https://ClinicalTrials.gov/show/NCT00371995 |
Completed |
Banaras Hindu University |
2009-08-31 |
| NCT00370825 |
Combination Chemotherapy for the Treatment of Indian Kala-Azar |
https://ClinicalTrials.gov/show/NCT00370825 |
Completed |
Banaras Hindu University |
NA |
| NCT00351520 |
Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica |
https://ClinicalTrials.gov/show/NCT00351520 |
Completed |
Tehran University of Medical Sciences |
NA |
| NCT00318721 |
Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar |
https://ClinicalTrials.gov/show/NCT00318721 |
Completed |
London School of Hygiene and Tropical Medicine |
2008-12-31 |
| NCT00317980 |
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00317980 |
Completed |
University of Brasilia |
2008-03-31 |
| NCT00310505 |
Amphotericin B Treatment in Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00310505 |
Completed |
Banaras Hindu University |
NA |
| NCT00257530 |
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00257530 |
Completed |
Drugs for Neglected Diseases |
2006-06-30 |
| NCT00255567 |
Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00255567 |
Completed |
Drugs for Neglected Diseases |
2010-01-31 |
| NCT00233545 |
Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia |
https://ClinicalTrials.gov/show/NCT00233545 |
Completed |
AB Foundation |
NA |
| NCT00216346 |
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00216346 |
Completed |
PATH |
NA |
| NCT00121862 |
Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite |
https://ClinicalTrials.gov/show/NCT00121862 |
Completed |
IDRI |
NA |
| NCT00121849 |
Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite |
https://ClinicalTrials.gov/show/NCT00121849 |
Completed |
IDRI |
NA |
| NCT00111553 |
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00111553 |
Completed |
IDRI |
NA |
| NCT00111514 |
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis |
https://ClinicalTrials.gov/show/NCT00111514 |
Completed |
IDRI |
NA |
| NCT00818818 |
Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients |
https://ClinicalTrials.gov/show/NCT00818818 |
Completed |
University of Brasilia |
2010-01-31 |
| NCT00001906 |
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants |
https://ClinicalTrials.gov/show/NCT00001906 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004755 |
Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil |
https://ClinicalTrials.gov/show/NCT00004755 |
Completed |
Office of Rare Diseases (ORD) |
NA |